![](/img/cover-not-exists.png)
3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy
Yi, Dag Heiro, Stetter, Nadine, Jakobsen, Kjerstin, Jonsson, Roland, Appel, SilkeLanguage:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-018-2216-y
Date:
August, 2018
File:
PDF, 1.17 MB
english, 2018